• Ibruxen (Ibrutinib 140mg) Quick View
    • Ibruxen (Ibrutinib 140mg) Quick View
    • ,
    • Ibruxen (Ibrutinib 140mg)

    • Ibruxen 140mg is a prescription medication used to treat various conditions related to inflammation and pain management. This post aims to provide an in-depth look at Ibruxen 140mg, detailing its indications, pharmacology, dosage, side effects, interactions, and more. By the end of this article, you will have a clearer understanding of this medication and its role in healthcare.
    • Read more
  • Ivosenib 250mg (Ivosidenib) Quick View
    • Ivosenib 250mg (Ivosidenib) Quick View
    • ,
    • Ivosenib 250mg (Ivosidenib)

    • Ivosenib 250mg (Ivosidenib 250mg) is a groundbreaking medication designed to Treatment Acute Myeloid Leukemia (AML), particularly in patients with a specific genetic mutation called IDH1. This targeted therapy offers new hope for patients whose cancer is resistant to conventional treatments, providing a highly specialized approach that can transform the course of this aggressive blood cancer.  
    • Read more
  • Lenvanix 10mg & 4mg (Lenvatinib)Lenvanix 10mg & 4mg (Lenvatinib) Quick View
    • Lenvanix 10mg & 4mg (Lenvatinib)Lenvanix 10mg & 4mg (Lenvatinib) Quick View
    • , ,
    • Lenvanix 10mg & 4mg (Lenvatinib)

    •  Lenvanix (Lenvatinib)  is a powerful cancer-fighting medication available in  10 mg  and  4 mg  doses. As a targeted therapy, Lenvanix plays a critical role in treating advanced thyroid cancer, liver cancer (hepatocellular carcinoma), and renal cell carcinoma (kidney cancer). This oral medication works by inhibiting proteins in cancer cells that promote tumour growth, helping to slow or even stop the…
    • Read more
  • Lenvaxen 10 mg (Lenvatinib) Quick View
    • Lenvaxen 10 mg (Lenvatinib) Quick View
    • , ,
    • Lenvaxen 10 mg (Lenvatinib)

    • Lenvaxen 10 mg (Lenvatinib) is an innovative oral medication designed to treat several types of advanced cancers, including thyroid cancer, renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC). The active ingredient, Lenvatinib, is a multi-targeted tyrosine kinase inhibitor (TKI) that works by blocking the signals that promote the growth of cancer cells and the formation of blood vessels that supply…
    • Read more
  • Lenvaxen 4 mg & 10 mg (Lenvatinib)Lenvaxen 4 mg & 10 mg (Lenvatinib) Quick View
    • Lenvaxen 4 mg & 10 mg (Lenvatinib)Lenvaxen 4 mg & 10 mg (Lenvatinib) Quick View
    • , ,
    • Lenvaxen 4 mg & 10 mg (Lenvatinib)

    • Lenvaxen (Lenvatinib) is a powerful oral medication used to treat various types of cancer, including thyroid cancer, renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC). The active ingredient in Lenvaxen is lapatinib, a tyrosine kinase inhibitor (TKI) that works by blocking multiple enzymes responsible for the growth and spread of cancer cells. This targeted approach helps slow down tumour growth,…
    • Read more
  • Lenvaxen 4mg (Lenvatinib) Quick View
    • Lenvaxen 4mg (Lenvatinib) Quick View
    • , ,
    • Lenvaxen 4mg (Lenvatinib)

    • Lenvaxen 4mg (Lenvatinib) is a powerful, targeted cancer therapy specifically designed to treat advanced thyroid cancer, hepatocellular carcinoma (liver cancer), and renal cell carcinoma (kidney cancer). This innovative medication inhibits specific proteins that promote tumour growth and spread, slowing cancer progression. Lenvaxen 4mg has become a trusted choice for oncologists worldwide due to its efficacy in targeting multiple cancer types,…
    • Read more
  • Lorbrexen 100mg (lorlatinib) | Quick View
    • Lorbrexen 100mg (lorlatinib) | Quick View
    • Lorbrexen 100mg (lorlatinib) |

    •  Lorbrexen 100 mg (lorlatinib)  is an innovative oral medication used to treat non-small cell lung cancer (NSCLC)  in patients with a specific gene mutation known as  ALK-positive . This cutting-edge therapy is designed to slow the progression of Cancer, offering hope for patients in the advanced stages of Treatment For Lung Cancer where other treatments may have failed. With Lorbrexen,…
    • Read more
  • Lorlatinib(Lorbrexen 100mg) Quick View
    • Lorlatinib(Lorbrexen 100mg) Quick View
    • ,
    • Lorlatinib(Lorbrexen 100mg)

    • Lorbrexen (Lorlatinib 100mg) is an innovative cancer therapy specifically designed to treat non-small cell lung cancer (NSCLC) that is positive for ALK (anaplastic lymphoma kinase) mutations. This targeted therapy is highly effective in managing advanced stages of ALK-positive NSCLC, especially in patients whose cancer has progressed despite prior treatment with other ALK inhibitors. Lorbrexen works by blocking the activity of…
    • Read more
  • Mobocertinib 40 mg (Moboxen) Quick View
    • Mobocertinib 40 mg (Moboxen) Quick View
    • Mobocertinib 40 mg (Moboxen)

    • Unlock a new avenue of hope in targeted cancer therapy with Mobocertinib 40 mg (Moboxen), a cutting-edge therapy specifically designed for patients with non-small cell lung cancer (NSCLC) harboring specific EGFR mutations. With a focus on precision medicine, Mobocertinib offers a targeted approach that aims to inhibit tumor growth while minimizing side effects, making it a valuable option for those…
    • Read more
  • Niranib 100mg (Niraparib) Quick View
    • Niranib 100mg (Niraparib) Quick View
    • ,
    • Niranib 100mg (Niraparib)

    • Niranib 100mg (Niraparib) is an advanced oral medication used for the maintenance treatment of ovarian, fallopian tube, and primary peritoneal cancers. It's part of a group of cancer treatments known as PARP inhibitors, which target and destroy cancer cells by preventing them from repairing their DNA. Niranib offers new hope for patients who are in remission following successful treatment with…
    • Read more
  • Obetix 5 mg (Obeticholic AC) Quick View
    • Obetix 5 mg (Obeticholic AC) Quick View
    • ,
    • Obetix 5 mg (Obeticholic AC)

    • Obetix 5 mg (Obeticholic Acid) is a breakthrough medication designed to treat primary biliary cholangitis (PBC), a chronic liver disease that causes inflammation and damage to the bile ducts. Obeticholic acid, the active ingredient in Obetix, works by activating the farnesoid X receptor (FXR), a key regulator in bile acid metabolism. This helps reduce liver inflammation and damage, slowing the…
    • Read more
  • Olanib 50mg & 150mg (Olaparib)Olanib 50mg & 150mg (Olaparib) Quick View
    • Olanib 50mg & 150mg (Olaparib)Olanib 50mg & 150mg (Olaparib) Quick View
    • , ,
    • Olanib 50mg & 150mg (Olaparib)

    • Olanib 50mg & 150mg (Olaparib) is a leading-edge oral medication used to treat various cancers, specifically ovarian, breast, prostate, and pancreatic cancers. This powerful drug belongs to a class of treatments known as PARP Inhibitor For Prostate Cancer (Poly ADP-Ribose Polymerase inhibitors). It is designed to stop cancer cells from repairing themselves, slowing tumour growth and enhancing survival rates.   
    • Read more